In breast cancer, Notch1 enhances cancer cell proliferation and sustains cancer stem cell activity, whereas Notch3 suppresses epithelial-mesenchymal transition (EMT) by activating glycogen synthase kinase 3 beta (GSK3β) expression (44). Here, NOTCH3 is linked to breast carcinoma.